Sun BioPharma, Inc. Contracts & Agreements

Senior Convertible Promissory Tranche B Note issued to Nant Capital, LLC, dated November 15, 2024 (Filed With SEC on November 18, 2024)

Waiver, by and among Panbela Therapeutics, Inc., Cancer Prevention, Pharmaceuticals, LLC and USWM, LLC. dated October 2, 2024 (Filed With SEC on November 14, 2024)

Subordinated Promissory Note, dated as of August 19, 2024 (Filed With SEC on November 14, 2024)

Subordination Agreement, dated as of August 19, 2024 (Filed With SEC on November 14, 2024)

Note Purchase Agreement, dated October 22, 2024, between Nant Capital, LLC, as Investor, and Panbela Therapeutics, Inc., as Company (Filed With SEC on October 28, 2024)

Senior Convertible Promissory Tranche A Note issued to Nant Capital, LLC, dated October 22, 2024 (Filed With SEC on October 28, 2024)

Continuing Guaranty Agreement, dated October 22, 2024, made by Cancer Prevention Pharmaceuticals, Inc. and Panbela Research, Inc., in favor of Nant Capital, LLC (Filed With SEC on October 28, 2024)

Retention Agreement with Jennifer K. Simpson dated September 23, 2024 (Filed With SEC on September 27, 2024)

Retention Agreement with Susan Horvath dated September 23, 2024 (Filed With SEC on September 27, 2024)

Waiver by and among Panbela Therapeutics, Inc., Cancer Prevention, Pharmaceuticals, LLC and USWM, LLC, dated August 8, 2024 (Filed With SEC on August 13, 2024)

Subordinated Promissory Note, dated as of August 8, 2024 (Filed With SEC on August 13, 2024)

Subordination Agreement, dated as of August 8, 2024 (Filed With SEC on August 13, 2024)

Loan Agreement, dated July 24, 2024, by and among USWM, LLC, as lender, and Panbela Therapeutics, Inc. and Cancer Prevention Pharmaceuticals, Inc., as borrowers (Filed With SEC on July 30, 2024)

Term Promissory Note issued to USWM, LLC, dated July 24, 2024 (Filed With SEC on July 30, 2024)

Security Agreement, dated July 24, 2024, made by Panbela Therapeutics, Inc. and Cancer Prevention Pharmaceuticals, Inc. in favor of USWM, LLC (Filed With SEC on July 30, 2024)

Subscription and Investment Representation Agreement, dated April 23, 2024, by and between Panbela Therapeutics, Inc. and Michael T. Cullen (Filed With SEC on April 25, 2024)

Form of Retention Agreements dated February 7, 2024 (Filed With SEC on February 13, 2024)

Form of Class E Common Stock Purchase Warrant (Filed With SEC on January 29, 2024)

Form of Class F Common Stock Purchase Warrant (Filed With SEC on January 29, 2024)

Placement Agency Agreement dated as of January 28, 2024 by and between Panbela Therapeutics, Inc. and Roth Capital Partners, LLC (Filed With SEC on January 29, 2024)

Form of Securities Purchase Agreement dated as of January 28, 2024 by and between Panbela Therapeutics, Inc. and the purchasers named therein (Filed With SEC on January 29, 2024)

Form of Class E Common Stock Purchase Warrant (Filed With SEC on January 25, 2024)

Form of Securities Purchase Agreement (Filed With SEC on January 25, 2024)

Form of Warrant Agency Agreement with VStock Transfer, LLC (Filed With SEC on January 4, 2024)

Form of Class E Common Stock Purchase Warrant (Filed With SEC on January 4, 2024)

Form of Class F Common Stock Purchase Warrant (Filed With SEC on January 4, 2024)

CLASS F COMMON STOCK PURCHASE WARRANT PANBELA THERAPEUTICS, INC. (Filed With SEC on January 4, 2024)

Form of Placement Agency Agreement with Roth Capital Partners, LLC (Filed With SEC on January 4, 2024)

Form of Securities Purchase Agreement (Filed With SEC on January 4, 2024)

Form of Inducement Warrant (Filed With SEC on December 21, 2023)

Form of Inducement Letter (Filed With SEC on December 21, 2023)

Form of Inducement Warrant (Filed With SEC on November 3, 2023)

Form of Inducement Letter (Filed With SEC on November 3, 2023)

Warrant Agency Agreement dated as of June 21, 2023 by and between Panbela Therapeutics, Inc. and VStock Transfer, LLC (Filed With SEC on June 21, 2023)

Form of Pre-Funded Common Stock Purchase Warrant (Filed With SEC on June 21, 2023)

Form of Class A Common Stock Purchase Warrant (Filed With SEC on June 21, 2023)

Form of Class B Common Stock Purchase Warrant (Filed With SEC on June 21, 2023)

Placement Agency Agreement dated as of June 16, 2023 by and between Panbela Therapeutics, Inc. and Roth Capital Partners, LLC (Filed With SEC on June 21, 2023)

Form of Securities Purchase Agreement by and between Panbela Therapeutics, Inc. and the purchasers named therein (Filed With SEC on June 21, 2023)

Form of Warrant Agency Agreement (Filed With SEC on June 2, 2023)

Form of Class A Common Stock Purchase Warrant (Filed With SEC on June 2, 2023)

Form of Class B Common Stock Purchase Warrant (Filed With SEC on June 2, 2023)

Form of Pre-Funded Warrant (Filed With SEC on June 2, 2023)

Form of Securities Purchase Agreement (Filed With SEC on June 2, 2023)

Form of Placement Agency Agreement (Filed With SEC on June 2, 2023)

Subscription and Investment Representation Agreement, dated April 14, 2023, by and between Panbela Therapeutics, Inc. and Michael T. Cullen (Filed With SEC on April 18, 2023)

Warrant Agency Agreement dated as of January 30, 2023 by and between Panbela Therapeutics, Inc. and VStock Transfer, LLC (Filed With SEC on January 31, 2023)

Form of Pre-Funded Common Stock Purchase Warrant (Filed With SEC on January 31, 2023)

Form of Common Stock Purchase Warrant (Filed With SEC on January 31, 2023)

Placement Agency Agreement dated as of January 26, 2023 by and between Panbela Therapeutics, Inc. and Roth Capital Partners, LLC (Filed With SEC on January 31, 2023)

Form of Securities Purchase Agreement by and between Panbela Therapeutics, Inc. and the purchasers named therein (Filed With SEC on January 31, 2023)

Form of Warrant Agency Agreement (Filed With SEC on January 23, 2023)

Form of Common Stock Purchase Warrant (Filed With SEC on January 23, 2023)

Form of Warrant Agency Agreement (Filed With SEC on January 18, 2023)

Form of Common Stock Purchase Warrant (Filed With SEC on January 18, 2023)

Form of Pre-Funded Warrant (Filed With SEC on January 18, 2023)

Form of Securities Purchase Agreement (Filed With SEC on January 18, 2023)

Form of Placement Agency Agreement (Filed With SEC on January 18, 2023)

Warrant Agency Agreement dated as of October 4, 2022 by and between Panbela Therapeutics, Inc. and VStock Transfer, LLC (Filed With SEC on October 4, 2022)

Form of Pre-Funded Common Stock Purchase Warrant (Filed With SEC on October 4, 2022)

Form of Common Stock Purchase Warrant (Filed With SEC on October 4, 2022)

Placement Agency Agreement dated as of September 29, 2022 by and between Panbela Therapeutics, Inc. and Roth Capital Partners, LLC (Filed With SEC on October 4, 2022)

Form of Securities Purchase Agreement by and between Panbela Therapeutics, Inc. and the purchasers named therein (Filed With SEC on October 4, 2022)

Form of Common Stock Purchase Warrant (Filed With SEC on September 6, 2022)

Form of Pre-Funded Warrant (Filed With SEC on September 6, 2022)

Form of Warrant Agency Agreement (Filed With SEC on September 6, 2022)

Form of Securities Purchase Agreement (Filed With SEC on September 6, 2022)

Form of Placement Agency Agreement (Filed With SEC on September 6, 2022)

License Agreement, dated June 16, 2021 between Cancer Prevention Pharmaceuticals, Inc. and One-Two Therapeutic Assets Limited (Filed With SEC on August 15, 2022)

Sales Agreement, dated July 19, 2022 with Roth Capital Partners, LLC (Filed With SEC on July 20, 2022)

Dr. Suzanne Gagnon Consulting Agreement (Filed With SEC on March 24, 2022)

Agreement and Plan of Merger, dated February21, 2022, by and among Panbela Therapeutics, Inc., Canary Merger Holdings, Inc., Canary Merger Subsidiary I, Inc., Canary Merger... (Filed With SEC on February 22, 2022)

Amended and Restated Underwriting Agreement, dated June 29, 2021, by and between Panbela Therapeutics, Inc. and H.C. Wainwright & Co., LLC (Filed With SEC on July 2, 2021)

Description of Securities (Filed With SEC on March 25, 2021)

Underwriting Agreement dated August 28, 2020 (Filed With SEC on September 1, 2020)

Warrant Agency Agreement with VStock Transfer, LLC dated September 1, 2020 (Filed With SEC on September 1, 2020)

Form of Underwriting Agreement (Filed With SEC on August 27, 2020)

Form of Underwriting Agreement (Filed With SEC on August 20, 2020)

Form of Common Stock Purchase Warrant (Filed With SEC on August 20, 2020)

Form of Underwriter Common Stock Purchase Warrant (Filed With SEC on August 20, 2020)

Form of Warrant Agency Agreement (Filed With SEC on August 20, 2020)

Form of Employee Confidentiality and Intellectual Property Assignment Agreement with Company Officers (Filed With SEC on August 11, 2020)

Employment Agreement with Jennifer K. Simpson, effective July 15, 2020 (Filed With SEC on July 16, 2020)

Form of Securities Purchase Agreement (Filed With SEC on June 11, 2020)

Form of Warrant (Filed With SEC on June 11, 2020)

Description of Securities (Filed With SEC on March 24, 2020)

Form of First Amendment to License Agreement with University of Florida Research Foundation, Inc. dated December 12, 2016 (Filed With SEC on March 24, 2020)

Seed Capital Accelerator Loan Agreement and Seed Capital Loan Note dated October 26, 2012 (Filed With SEC on March 24, 2020)

Third Amendment to Seed Capital Accelerator Loan Agreement and Seed Capital Loan Noted dated December 31,2019 (Filed With SEC on March 24, 2020)

Second Amendment to License Agreement No. A9672 between Sun BioPharma, Inc. and University of Florida Research Foundation, Inc., dated as of October 3, 2019 (Filed With SEC on October 9, 2019)

Form of Securities Purchase Agreement (Filed With SEC on August 29, 2019)

Form of Warrant (Filed With SEC on August 29, 2019)

Amendment to Seed Capital Accelerator Loan Agreement and Seed Capital Loan Note dated October 13, 2017 (Filed With SEC on May 14, 2019)

Second Amendment to Seed Capital Accelerator Loan Agreement and Seed Capital Loan Note dated April 5, 2019 (Filed With SEC on May 14, 2019)

Form of Warrant issued April 2, 2019 (Filed With SEC on May 14, 2019)

Form of Securities Purchase Agreement, by and among the Company and Investors (Filed With SEC on December 28, 2018)

Form of Convertible Promissory Note (Filed With SEC on December 28, 2018)

Form of Common Stock Warrant (Filed With SEC on December 28, 2018)

Consulting Agreement with David Kaysen, dated October 31, 2018 (Filed With SEC on November 1, 2018)

Employment Agreement with Susan Horvath, effective as of April 17, 2018 (Filed With SEC on May 14, 2018)

Sun Biopharma, Inc. 2016 Omnibus Incentive Plan, amended and restated as of March 14, 2018 (Filed With SEC on March 20, 2018)

Waiver and Third Amendment to Employment Agreement with Michael T. Cullen, effective as of February 27, 2018 (Filed With SEC on March 5, 2018)

Waiver and Third Amendment to Employment Agreement with David B. Kaysen, effective as of February 27, 2018 (Filed With SEC on March 5, 2018)

Waiver and Third Amendment to Employment Agreement with Scott Kellen, effective as of February 27, 2018 (Filed With SEC on March 5, 2018)

Waiver and Third Amendment to Employment Agreement with Suzanne Gagnon, effective as of February 27, 2018 (Filed With SEC on March 5, 2018)

Form of Securities Purchase Agreement, dated February 20, 2018 (Filed With SEC on February 26, 2018)

Form of Warrant (Filed With SEC on February 26, 2018)

Standstill Agreement with Ryan R. Gilbertson, dated December 17, 2017 (Filed With SEC on December 18, 2017)

Form of Underwriting Agreement (Filed With SEC on December 18, 2017)

Form of Warrant Agreement (Filed With SEC on December 18, 2017)

Form of Representatives Warrant (Filed With SEC on December 18, 2017)

Second Amendment to Employment Agreement with Michael T. Cullen, effective as of October 1, 2017 (Filed With SEC on October 13, 2017)

Second Amendment to Employment Agreement with David B. Kaysen, effective as of October 1, 2017 (Filed With SEC on October 13, 2017)

Second Amendment to Employment Agreement with Scott Kellen, effective as of October 1, 2017 (Filed With SEC on October 13, 2017)

Second Amendment to Employment Agreement with Suzanne Gagnon, effective as of October 1, 2017 (Filed With SEC on October 13, 2017)

[FORM OF] DEBT-FOR-EQUITY EXCHANGE AGREEMENT (Filed With SEC on March 31, 2017)

[FORM OF] PARTICIPATION RIGHTS AGREEMENT (Filed With SEC on March 31, 2017)

SUN BIOPHARMA, INC. 2016 Omnibus Incentive Plan Performance-Based Stock Option Agreement (Filed With SEC on March 30, 2017)

NOTE PURCHASE AGREEMENT (Filed With SEC on March 6, 2017)

SUN BIOPHARMA, INC. CONVERTIBLE PROMISSORY NOTE (Filed With SEC on March 6, 2017)

FIRST AMENDMENT TO EMPLOYMENT AGREEMENT (Filed With SEC on September 16, 2016)

AGREEMENT AND PLAN OF MERGER (Filed With SEC on August 11, 2016)

SUN BIOPHARMA, INC. 2016 Omnibus Incentive Plan Incentive Stock Option Agreement (Filed With SEC on August 11, 2016)

SUN BIOPHARMA, INC. 2016 Omnibus Incentive Plan Non-Qualified Stock Option Agreement (Filed With SEC on August 11, 2016)

SECURITIES PURCHASE AGREEMENT (Filed With SEC on June 14, 2016)

SUN BIOPHARMA, INC. WARRANT (Filed With SEC on June 14, 2016)

EMPLOYMENT AGREEMENT (Filed With SEC on March 8, 2016)

EMPLOYMENT AGREEMENT (Filed With SEC on December 4, 2015)

SUN BIOPHARMA, INC. CONVERTIBLE PROMISSORY NOTE (Filed With SEC on September 11, 2015)

WARRANT TO PURCHASE SHARES OF STOCK of SUN BIOPHARMA, INC. (Filed With SEC on September 11, 2015)

SUN BIOPHARMA, INC. 2011 STOCK OPTION PLAN (Filed With SEC on September 11, 2015)

INCENTIVE STOCK OPTION AGREEMENT OF SUN BIOPHARMA, INC. (with advance purchase rights) (Filed With SEC on September 11, 2015)

NON-QUALIFIED STOCK OPTION AGREEMENT OF SUN BIOPHARMA, INC. (with advance purchase rights) (Filed With SEC on September 11, 2015)

INDEMNIFICATION AGREEMENT (Filed With SEC on September 11, 2015)

STANDARD EXCLUSIVE LICENSE AGREEMENT WITH KNOW HOW - Agreement No: A9672 TABLE OF CONTENTS (Filed With SEC on September 11, 2015)

AMENDMENT NO. 1 TO AGREEMENT AND PLAN OF MERGER (Filed With SEC on August 5, 2015)

AGREEMENT AND PLAN OF MERGER BY AND AMONG CIMARRON MEDICAL, INC., SUN BIOPHARMA, INC., AND SB ACQUISITION CORPORATION (Filed With SEC on June 18, 2015)

Category

Industry

Companies

Contracts

Sun BioPharma, Inc. Contracts & Agreements